Overview

ORCA - Oracea® for Rosacea: A Community-based Assessment

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the effectiveness, safety, subject satisfaction and quality of life with Oracea® when used as monotherapy or as add-on therapy to existing topical regimens for the treatment of rosacea.
Phase:
Phase 4
Details
Lead Sponsor:
Galderma Laboratories, L.P.
Treatments:
Doxycycline